Recommendation ID
NICE encourages further research on ultra-radical (extensive) surgery for advanced ovarian cancer, either in the form of research trials or in audits intended for publication (ideally by collaboration between units). Clinicians should ensure that details of patient selection and the precise extent of surgery are fully documented. Reported outcomes should include all complications, survival, and quality of life. Trials comparing complication rates, survival and quality of life against those of standard surgery and chemotherapy would be especially useful.
Any explanatory notes
(if applicable)
Current evidence on the safety and efficacy of ultra-radical (extensive) surgery for advanced ovarian cancer is inadequate. Therefore this procedure should not be done except with special arrangements for clinical governance, consent and audit or research (with the objective of publishing outcomes for all patients having this procedure).

Source guidance details

Comes from guidance
Ultra-radical (extensive) surgery for advanced ovarian cancer
Date issued
November 2013

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 19/12/2013